North China Pharmaceutical Company.,Ltd.’s Net Profit Dropped 82.3% in First Three Quarters of 2021

North China Pharmaceutical Company.,Ltd. (华北制药股份有限公司) (600812.SH) reported a net profit of 24.3 million yuan in the first three quarters of 2021, down 82.3% year-on-year.

Meanwhile, the company posted 8.2 billion yuan in revenue, down 9.7% year-on-year.

At the end of the reporting period, it had 25.6 billion yuan in total assets and 18.6 billion yuan in total liabilities, with a liability-to-asset ratio of 72.6%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.